News & Analysis on Clinical Trial Services & Contract Research And Development
Catalent Pharma Solutions, the firm born from the spin out of Cardinal Health's contract manufacturing business, is reorganising its production facilities with an expansion of its UK site and the divestiture of some of its French operations.
UK researchers have developed a plastic cell scaffold that enables cells to be grown in realistic 3D structures and promises to enable better cell based drug screening results.
Roche has just had the child-size, lower strength version of its blockbuster flu treatment Tamiflu (oseltamivir) approved by EU authorities, though possibly just a little too late for this year's flu season.
Swiss supplier and services provider Lonza has added another product to its catalogue of cell culture media, the most recent addition to the offering of its new bioscience unit.
SkyePharma is looking towards a positive future despite a pre-tax operating loss of £14.1m (€20.3m), announced in the UK company's unaudited six-month results.
Chinese drug manufacturers could be given a 24-hour deadline by regulators to pull unsafe pharmaceuticals off the market or face a fine, a Chinese newspaper reported.
Pennsylvania-based ARx has officially opened a new pharmaceutical manufacturing facility as it races to meet demand for its drug delivery components and keep up with the times.
Applied Biosystems (ABI) has successfully protected more of its PCR (polymerase chain reaction) patents with Agilent agreeing to license its thermal cycler technology.
The burgeoning US contract assay services arena has witnessed the arrival of a brand new player with the launch of ReachBio, which is opening its business operations this week.